Not possible to specify

450 trials 101 recruiting

Filter these 450 trials by phase, country and sponsor.

Open in Search →

A study in healthy men to test how bosentan influences the amount of zongertinib in the blood Recruiting

2025-523193-16-00 Healthy volunteer trial 3 2026-06-16
A Safety Study to Test a New Medicine (ANT3310) Alone and When Taken with an Antibiotic (Meropenem) in Healthy Adult Participants. Recruiting

2026-526411-11-00 Not applicable for phase I study 3 2026-06-15
Phase IV, randomized, open label, parallel groups clinical trial for evaluating the early Stop of antibiotic Treatment in high-risk febrile … Recruiting

2025-524264-38-00 Infectious diseases 6 2026-06-02
A PHASE 1, OPEN-LABEL STUDY TO ASSESS THE ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION, INCLUDING THE MASS BALANCE, OF A SINGLE ORAL … Recruiting

2025-524832-20-00 Healthy volunteers 3 2026-06-01
A Study of GEN1106 in Participants with Solid Tumors Recruiting

2025-523760-21-00 Metastatic or advanced malignant solid tumors 1 2026-05-28
Phase 1 clinical trial to evaluate the safety, tolerability, and pharmacokinetics of intravenous single ascending doses of IM-250 in healthy… Recruiting

2025-523146-27-00 Herpes simplex virus encephalitis 3 2026-05-26
A Phase 3 study of Hetrombopag in patients with low blood platelet count (thrombocytopenia) caused by chemotherapy Recruiting

2025-524209-34-00 Chemotherapy induced thrombocytopenia 5 2026-05-20
Study on the influence of FLUMAzenil regarding the incidence of pediatric emergence delirium (ED) in children undergoing ENT surgery – FLUMA… Recruiting

2025-523543-36-00 pediatric emergence delirium 11 2026-05-18
PHARMACOKINETICS OF PETRELINTIDE FOLLOWING ADMINISTRATION TO PARTICIPANTS WITH IMPAIRED HEPATIC FUNCTION Recruiting

2025-523641-10-00 Healthy / hepatic impaired volunteers only study to ass 3 2026-05-18
A research study looking into blood levels of the medicine NNC0487 0111 in the body and how well it is tolerated in people with reduced live… Recruiting

2025-521647-20-00 hepatic impairment 3 2026-05-12
A study to test how different doses of BI 3814916 are tolerated by healthy people Recruiting

2025-523262-25-00 healthy volunteer trial 1 2026-05-11
Evaluation of postoperative recovery when combining intravenous lidocaine with ropivacaine infiltration in laparoscopic colorectal oncologic… Recruiting

2025-523207-29-00 colorectal cancer laparoscopic surgery 6 2026-04-24
Phase 1, Randomized, Open-label, Single center study to evaluate Pharmacokinetic and Bioequivalence of Levonorgestrel Vaginal Delivery Syste… Recruiting

2025-524330-25-00 No medical condition 3 2026-04-21
A study in healthy men to test how well different doses of BI 3821001 are tolerated Recruiting

2025-523899-23-00 Healthy volunteer trial 1 2026-04-15
Immunosuppression regimen reduction in kidney transplantation recipients admitted to the intensive care unit in the setting of septic shock … Recruiting

2024-518493-14-00 kidney transplant 10 2026-04-10
A research study looking at how NNC0487-0111 affects food intake, appetite and metabolism after meals in people with obesity Recruiting

2025-521393-34-00 Participants with obesity, but otherwise healthy 3 2026-03-19
ADCX-020 for the treatment of patients with locally advanced or metastatic cancers Recruiting

2025-523959-65-00 Locally Advanced or Metastatic Solid Tumors 1 2026-03-17
A trial to learn how well AZD4144 works, how safe it is, and how it moves throughout the body over time in adults with acute kidney injury c… Recruiting

2025-522232-13-00 Sepsis-associated acute kidney injury (AKI) 4 2026-03-06
The POWER trial: A randomised, two-armed open label phase 3 clinical trial on personalised dose optimisation with adjuvant tamoxifen therapy… Recruiting

2025-522240-40-00 Breast Cancer 5 2026-03-05
The PEARL trial: Prevention of hepatic Encephalopathy by administration of Rifaximin and Lactulose in patients with liver cirrhosis undergoi… Recruiting

2024-512040-28-01 Confirmed diagnosis of Alcoholic liver cirrhosis 6 2026-03-01
First-in-Human Study of RO7812653 Recruiting

2025-522101-37-00 Early Symptomatic Alzheimer’s Disease (eAD), (Mild Cogn 1 2026-02-17
Study of exposure to substances prohibited by the World Anti-Doping Agency in healthy volunteers (ESPAMA_4). Proof of concept Recruiting

2025-521814-25-01 Healthy volunteers 3 2026-02-11
Phase 1 Single Ascending Doses (SAD) of M5542 in Healthy Participants Recruiting

2024-513069-37-00 Healthy 1 2026-01-30
A Study to Learn About the Investigational Medicine Called Mevrometostat (PF-06821497) in Men With Metastatic Castration-Sensitive Prostate … Recruiting

2024-519369-24-00 METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER 5 2026-01-29